EUVIMEDEUVIMED entdecken
Crossref

Fh15 Modulates Human Neutrophil Activation and Reduces NETosis 2335416

María Del Mar Figueroa-Gispert, Andrea Rivera-Torres, Ana Espino, Marcos Ramos-Benitez

The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)

DOI: 10.1093/jimmun/vkag141.1891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von María Del Mar Figueroa-Gispert und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Neutrophils are essential innate immune effectors, however, excessive activation can exacerbate inflammatory disease. A key pathogenic mechanism is neutrophil extracellular traps (NETs) formation, in which neutrophils release chromatin structures with antimicrobial proteins. While NETs can aid antimicrobial defense, dysregulated NETosis amplifies inflammation, promotes endothelial/epithelial damage, and has been linked to severe outcomes in conditions such as sepsis, autoimmune disease, and acute respiratory distress syndrome. Fh15, a recombinant Fasciola hepatica fatty acid-binding protein, is a parasite-derived immunomodulator with demonstrated anti-inflammatory activity in septic shock and ulcerative colitis. Fh15 has been shown to reduce neutrophils in inflamed colonic tissue and to decrease systemic myeloperoxidase, supporting an impact on neutrophil-associated inflammation. Here, we investigate whether Fh15 directly limits NETs and modulates neutrophil activation under pro-inflammatory stimulation.

Methods

Primary human neutrophils were stimulated with lipopolysaccharide (LPS) and treated with Fh15 at 5, 10, or 25 µg/mL. NETs formation was quantified using 6-hour live-cell imaging. Neutrophil activation was assessed by flow cytometry based on surface expression of CD11b, CD62L, and CD16.

Results

Fh15 reduced NETosis at 10 (p < 0.001) and 25 (p < 0.0001) µg/mL. Flow cytometry analysis showed that LPS reduced CD11b+CD16+ neutrophils (p < 0.0001), consistent with inflammation-associated shedding or downregulation of surface CD16. In contrast, Fh15 treatment increased the percentage of CD11b+CD16+ cells compared with LPS alone (p < 0.001).

Conclusion

Together, the data suggests that Fh15 helps preserve surface CD16 under pro-inflammatory stimulation. In conclusion, Fh15 dampens LPS-driven neutrophil effector responses, particularly NETs formation, and may modulate activation-associated phenotypes, supporting its potential as an immunomodulatory strategy to limit neutrophil-mediated tissue damage. Funding Source Funding was provided by the RCMI-CRRGMG (U54MD007579) and PR-INBRE DRPP (2P20GM103475-02). Topic Categories Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)

Zitieren

APA

Figueroa-Gispert, M. D. M., Rivera-Torres, A., Espino, A., & Ramos-Benitez, M. (2026). Fh15 Modulates Human Neutrophil Activation and Reduces NETosis 2335416. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1891

Vancouver

Figueroa-Gispert MDM, Rivera-Torres A, Espino A, Ramos-Benitez M. Fh15 Modulates Human Neutrophil Activation and Reduces NETosis 2335416. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1891

BibTeX
@article{FigueroaGispert2026,
  author = {Figueroa-Gispert, María Del Mar and Rivera-Torres, Andrea and Espino, Ana and Ramos-Benitez, Marcos},
  title = {Fh15 Modulates Human Neutrophil Activation and Reduces NETosis 2335416},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {Supplement_1},
  doi = {10.1093/jimmun/vkag141.1891}
}
Kostenlos starten →